NL8603209A - Nieuwe celgroei-regulerende factor. - Google Patents

Nieuwe celgroei-regulerende factor. Download PDF

Info

Publication number
NL8603209A
NL8603209A NL8603209A NL8603209A NL8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A NL 8603209 A NL8603209 A NL 8603209A
Authority
NL
Netherlands
Prior art keywords
polypeptide
amino acid
cells
sequence
poly
Prior art date
Application number
NL8603209A
Other languages
English (en)
Dutch (nl)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NL8603209A publication Critical patent/NL8603209A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL8603209A 1985-12-20 1986-12-17 Nieuwe celgroei-regulerende factor. NL8603209A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US81123585 1985-12-20
US93528386A 1986-11-26 1986-11-26
US93528386 1986-11-26

Publications (1)

Publication Number Publication Date
NL8603209A true NL8603209A (nl) 1987-07-16

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8603209A NL8603209A (nl) 1985-12-20 1986-12-17 Nieuwe celgroei-regulerende factor.

Country Status (29)

Country Link
JP (1) JP2559035B2 (pt)
KR (1) KR920005920B1 (pt)
CN (1) CN1017626B (pt)
AT (1) AT400444B (pt)
AU (2) AU601168B2 (pt)
BE (1) BE905957A (pt)
CA (1) CA1340296C (pt)
CH (1) CH675727A5 (pt)
CY (1) CY1608A (pt)
DE (2) DE3645095C2 (pt)
DK (1) DK174094B1 (pt)
ES (1) ES2003180A6 (pt)
FI (1) FI91484C (pt)
FR (1) FR2597108B1 (pt)
GB (1) GB2185485B (pt)
GR (1) GR862936B (pt)
HK (1) HK65691A (pt)
HU (1) HU210694B (pt)
IE (1) IE59415B1 (pt)
IL (1) IL81017A (pt)
IT (1) IT1213428B (pt)
LU (1) LU86718A1 (pt)
NL (1) NL8603209A (pt)
NO (1) NO174556C (pt)
NZ (1) NZ218634A (pt)
OA (1) OA08494A (pt)
PT (1) PT83986B (pt)
SE (1) SE505059C2 (pt)
SG (1) SG60891G (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315289A2 (en) * 1987-11-06 1989-05-10 Oncogen Cell growth inhibitory factor

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315289A2 (en) * 1987-11-06 1989-05-10 Oncogen Cell growth inhibitory factor
EP0315289A3 (en) * 1987-11-06 1990-04-11 Oncogen Cell growth inhibitory factor

Also Published As

Publication number Publication date
ATA340686A (de) 1995-05-15
JP2559035B2 (ja) 1996-11-27
AT400444B (de) 1995-12-27
CY1608A (en) 1992-04-03
AU6660886A (en) 1987-06-25
CN1017626B (zh) 1992-07-29
KR870005645A (ko) 1987-07-06
SE8605459D0 (sv) 1986-12-18
PT83986B (pt) 1989-07-31
IL81017A (en) 1993-01-14
SE8605459L (sv) 1987-06-21
IE863345L (en) 1987-06-20
IT8622787A0 (it) 1986-12-19
GB2185485B (en) 1990-07-04
FR2597108B1 (fr) 1991-02-15
HUT43103A (en) 1987-09-28
PT83986A (en) 1987-01-01
NZ218634A (en) 1991-06-25
NO174556B (no) 1994-02-14
NO865178L (no) 1987-06-22
GB8629997D0 (en) 1987-01-28
AU601168B2 (en) 1990-09-06
DE3643428C2 (pt) 1990-08-23
CN86108955A (zh) 1987-12-02
AU639048B2 (en) 1993-07-15
CA1340296C (en) 1998-12-29
NO865178D0 (no) 1986-12-19
NO174556C (no) 1994-05-25
ES2003180A6 (es) 1988-10-16
SG60891G (en) 1991-08-23
FR2597108A1 (fr) 1987-10-16
DE3643428A1 (de) 1987-09-24
HU210694B (en) 1995-06-28
CH675727A5 (pt) 1990-10-31
GB2185485A (en) 1987-07-22
SE505059C2 (sv) 1997-06-16
DE3645095C2 (de) 1993-11-18
AU6776590A (en) 1991-03-14
OA08494A (fr) 1988-07-29
IT1213428B (it) 1989-12-20
FI91484C (fi) 1994-07-11
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
DK615386D0 (da) 1986-12-18
KR920005920B1 (ko) 1992-07-24
FI91484B (fi) 1994-03-31
DK615386A (da) 1987-06-21
LU86718A1 (fr) 1988-07-14
DK174094B1 (da) 2002-06-10
BE905957A (fr) 1987-06-17
HK65691A (en) 1991-08-23
GR862936B (en) 1987-10-28
IE59415B1 (en) 1994-02-23
IL81017A0 (en) 1987-03-31
JPS62236498A (ja) 1987-10-16

Similar Documents

Publication Publication Date Title
Williams et al. Identification of a ligand for the c-kit proto-oncogene
Pober et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
JP3088983B2 (ja) 上皮細胞に特異的な成長因子をコードするｄｎａ
Levy et al. An endothelial cell growth factor from the mouse neuroblastoma cell line NB41
FI120312B (fi) Ihmisen kantasolutekijän valmistamiseksi soveltuva solu
CA2210644A1 (en) Ligands for eph-like receptors
NL8900178A (nl) Groei regulerende clycoproteinen.
CN112386678B (zh) 多肽或其衍生物的应用
CN1425066B (zh) 新的stra6多肽
Miyazono et al. Platelet-derived endothelial cell growth factor
JPH03195496A (ja) 成長因子
NL8603209A (nl) Nieuwe celgroei-regulerende factor.
Deuel et al. Platelet‐derived growth factor/sis in normal and neoplastic cell growth
Ginsburg et al. Stimulation of growth of human breast cancer cells (T47D) by platelet derived growth factor
Braunhut et al. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
Valente et al. Cultured primate aortic smooth muscle cells express both the PDGF‐‐A and PDGF‐B genes but do not secrete mitogenic activity or dimeric platelet‐derived growth factor protein
US5262298A (en) Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
Newcom et al. High molecular weight transforming growth factor β is excreted in the urine in active nodular sclerosing Hodgkin's disease
Witte et al. Growth factor production by a human megakaryocytic tumor cell line
Pennington et al. Dog mastocytoma cells secrete a growth factor for fibroblasts
US5071956A (en) Protein with vascular activity derived from monocytes and its analogues, a process for its extraction and their uses for therapeutic purposes and for the preparation of antibodies
US5147798A (en) Monophenotypic xenograft of megakaryocytic lineage and origin
FI98373B (fi) Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M
AU630873B2 (en) Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
Kelley Platelet-Derived Growth Factor, Transforming Growth Factor-β and Connective Tissue Growth Factor

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed